Track topics on Twitter Track topics that are important to you
Many patients with exacerbations of heart failure have significant concomitant kidney dysfunction. The combination of these two conditions makes pharmacological management difficult. In th...
In 2001, Scios Inc. caught international attention with the successful U.S. launch of NATRECOR® (nesiritide), the first new approved treatment for acute heart failure in more than a decade. To date, ...
Scios Inc. is a biopharmaceutical company engaged in the discovery, development, manufacture and commercialization of novel human therapeutics based upon its capabilities in both protein-...
Guilford Pharmaceuticals Inc. was founded in July 1993 by Scios Nova Inc., Dr. Solomon H. Snyder and Dr. Craig R. Smith to discover and develop novel pharmaceutical and biopolymer-based products that ...
We have published hundreds of Scios Inc. news stories on BioPortfolio along with dozens of Scios Inc. Clinical Trials and PubMed Articles about Scios Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scios Inc. Companies in our database. You can also find out about relevant Scios Inc. Drugs and Medications on this site too.